Boardroom Alpha
Boardroom Alpha
CVRX · Current Report (Form 8-K) · Filed March 3, 2026

Cvrx Inc — Current Report (Form 8-K)

Form
8-K
Filed
March 3, 2026
Period
Feb 27, 2026
Ticker
CVRX
Accession
0001104659-26-022952
Boardroom Alpha · Filing insights

CVRx grants incremental PSUs for 2026-2027 to executives, tied to cumulative revenue with performance-based vesting.

About Cvrx Inc
Market cap
$144M
1Y TSR
+1.3%
3Y TSR
−23.9%
Board grade
C
Sector
Healthcare
CEO
Kevin Hykes
Last annual meeting: Jun 1, 2026 · View full Cvrx Inc profile →

 

 

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): February 27, 2026

 

 

 

CVRx, Inc. 

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-40545   41-1983744
(State or other jurisdiction of
incorporation)
  (Commission
File Number)
  (I.R.S. Employer
Identification No.)

 

9201 West Broadway Avenue, Suite 650 

Minneapolis, MN 55445 

(Address of principal executive offices) (Zip Code)

 

(763) 416-2840 

(Registrant’s telephone number, including area code)

 

N/A 

(Former name or former address, if changed since last report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange
on which registered
Common stock, par value $0.01 per share   CVRX   The Nasdaq Global Select Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On February 27, 2026, at the same time as the Compensation Committee (the “Committee”) of the Board of Directors of CVRx, Inc. (the “Company”) approved annual equity awards for the Company’s executive officers, the Committee also approved an incremental equity award in the form of performance stock units (“PSU”) specific to a cumulative revenue goal for the fiscal 2026-2027 performance period. The PSUs were granted to all executive officers based on the Committee’s review of information regarding the retentive value of existing equity awards, criticality of achievement of near-term objectives and expected levels of future contributions. The grant date value of the PSUs granted to the named executive officers was equal to three-fourths of the value of their annual long-term incentives for fiscal 2026.

 

The PSUs are eligible to vest based on achievement of the cumulative revenue goal, with the amount of PSUs that can be earned ranging from 50% of target for performance at the threshold level to 200% of target for performance at the maximum level. The cumulative revenue goal is not disclosed due to its competitive sensitivity; however, the Committee believes the target goal represents meaningful revenue growth. Any earned PSUs will vest and be settled in shares of the Company’s common stock as follows: 50% upon certification of the cumulative revenue goal following the performance period and the remaining 50% on December 31, 2028, in each case subject to the executive’s continued employment through such dates, subject to certain provisions for accelerated or continued vesting in the event of death, disability, termination without cause or a “double trigger” event following a change in control, with the PSUs converting to time-based restricted stock units at the greater of the target or actual level of performance upon a change in control. The form of Performance Stock Unit Agreement is filed as Exhibit 10.1 hereto.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit
No.
  Description
10.1   Form of Performance Stock Unit Agreement (Executives – 2026-2027 Cumulative Revenue) pursuant to 2021 Equity Incentive Plan
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  CVRx, Inc.
   
Date: March 3, 2026 By: /s/ Jared Oasheim
    Name: Jared Oasheim
    Its: Chief Financial Officer

 

 

 

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Cvrx Inc (CVRX)

Reference

Frequently asked questions

When did Cvrx Inc file this 8-K?
Cvrx Inc (CVRX) filed this Current Report (Form 8-K) with the SEC on March 3, 2026. The accession number assigned by EDGAR is 0001104659-26-022952.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
CVRx grants incremental PSUs for 2026-2027 to executives, tied to cumulative revenue with performance-based vesting. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Cvrx Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Cvrx Inc has filed under CIK 1235912, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer